美敦力公司

MDT is the ticker symbol for Medtronic plc, a global medical technology company. Medtronic develops and manufactures a wide range of medical devices and therapies, including products for cardiac rhythm management, spinal and neurosurgical procedures, diabetes care, and minimally invasive surgeries. The company operates in more than 150 countries and is headquartered in Ireland, with significant operations in the United States.

Recent performance for MDT can be found on the stock detail page, where you can view the latest price change and percentage movement. For a broader view, compare the current price to the 52-week high and low. Performance often reflects company-specific news, earnings reports, and broader market conditions. Always check the most up-to-date figures displayed on the page for the latest information.

Common valuation metrics for MDT include the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio. Investors may also look at enterprise value-to-EBITDA (EV/EBITDA) and free cash flow yield. These metrics help compare MDT's valuation to its own history and to peers in the medical device industry. The specific values are available on the stock detail page.

MDT is listed on the New York Stock Exchange and is generally considered an actively traded large-cap stock. Its average daily trading volume can be found on the stock detail page. High liquidity typically means investors can buy or sell shares throughout the trading day with relatively tight bid-ask spreads. For the latest volume and liquidity data, refer to the figures displayed on the page.

Key financial metrics for MDT include revenue growth, gross and operating margins, net income, earnings per share (EPS), and free cash flow. Investors also examine return on equity (ROE) and return on invested capital (ROIC) to gauge profitability and efficiency. Additionally, debt levels and cash reserves provide insight into financial health. These metrics are reported in Medtronic's quarterly and annual financial statements.

Risks for MDT include regulatory changes affecting medical devices, product recalls or safety issues, intense competition, and reliance on successful product innovation. Currency fluctuations and global economic conditions can also impact results, as Medtronic operates worldwide. Additionally, pricing pressure from healthcare systems and slower adoption of new technologies may affect growth. Investors should review the risk factors disclosed in Medtronic's SEC filings for a comprehensive list.